Does Informant-Based Reporting of Cognitive Symptoms Predict Amyloid Positivity on Positron Emission Tomography?
Introduction: Researchers are searching for clinical instruments to predict amyloid positivity for disease classification. Informant-based reports could detect disease status. This study compares subjective memory complaints captured by informant-based reports between positron emission tomography (PET)â€“positive and PET-negative patients and hypothesizes that amyloid PET positivity associates with increased informant-based cognitive complaints. Methods: Ninety-eight amnestic mild cognitive impairment or mild dementia subjects were studied. Subjective report was captured by the informant-driven Alzheimer's Questionnaire (AQ) administered before PET. Differences in demographics and AQ score by diagnostic status and amyloid status were measured, and a receiver-operating characteristic curve was calculated. Results: Sixty-five mild cognitive impairment/Alzheimer's disease amyloid PET-positive and 33 amyloid PET-negative subjects were included. AQ was significantly higher (12.51 Â± 4.95) for amyloid PET-positive subjects (9.06 Â± 3.65; P = .001). Conclusions: Amyloid PET-positive subjects with Alzheimer's disease or mild cognitive impairment have more informant-based reports of cognitive decline, indicating utility for a brief informant measure.
Medical Subject Headings
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Digital Object Identifier (DOI)
Brunet, Hannah E.; Miller, Justin B.; Shi, Jiong; Chung, Briana; Munter, Bryce Taylor; and Sabbagh, Marwan Noel, "Does Informant-Based Reporting of Cognitive Symptoms Predict Amyloid Positivity on Positron Emission Tomography?" (2019). Neurology. 181.